Drug Profile
Research programme: cancer therapeutics - Aurigene Oncology/Ortho Biotech
Latest Information Update: 15 Jan 2024
Price :
$50
*
At a glance
- Originator Aurigene Discovery Technologies; Ortho Biotech Oncology Research & Development
- Developer Aurigene Oncology; Ortho Biotech Oncology Research & Development
- Class Small molecules
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in India
- 16 Dec 2008 Preclinical trials in Cancer in India (unspecified route)